1,206
Participants
Start Date
March 24, 2007
Primary Completion Date
July 12, 2007
Study Completion Date
June 10, 2008
H5N1 adjuvanted split virus vaccine (A/Vietnam/1194/2004 strain)
Two doses of the GSK1562902A adjuvanted split virus vaccine, administered intramuscularly into the deltoid region of the non-dominant arm at Day 0 and Day 21.
H5N1 non-adjuvanted split virus vaccine (A/Vietnam/1194/2004 strain)
Two doses of the GSK1562902A non-adjuvanted split virus vaccine, administered intramuscularly into the deltoid region of the non-dominant arm at Day 0 and Day 21.
H5N1 adjuvanted split virus vaccine (A/Indonesia/05/2005 strain)
Booster administration at Month 6 (and a second booster dose 21 days later for the un-adjuvanted group only) with an adjuvanted split virus pandemic influenza candidate vaccine containing the strain A/Indonesia/5/2005.
GSK Investigational Site, Taipei
GSK Investigational Site, Taipei
GSK Investigational Site, Bangkok
GSK Investigational Site, Singapore
GSK Investigational Site, Singapore
GSK Investigational Site, Hong Kong
Lead Sponsor
GlaxoSmithKline
INDUSTRY